Advertisement
Screener

Maravai LifeSciences Holdings, Inc. (MRVI) Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders

2.8 / 5 stars · 68/120 Roast Me

Maravai LifeSciences Holdings, Inc. Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders

Maravai LifeSciences Holdings, Inc. (MRVI) reported Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders of $494.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-18.

Financial Statements › Shareholders' Equity › Noncontrolling Interest Items

us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders · last filed 2025-11-07

  • Maravai LifeSciences Holdings, Inc. noncontrolling interest, decrease from distributions to noncontrolling interest holders for the quarter ending 2024-12-31 was -$78.00K.
  • Maravai LifeSciences Holdings, Inc. noncontrolling interest, decrease from distributions to noncontrolling interest holders for the quarter ending 2024-09-30 was $0.00.
  • Maravai LifeSciences Holdings, Inc. noncontrolling interest, decrease from distributions to noncontrolling interest holders for the quarter ending 2024-06-30 was $572.00K, a 56.17% decline year-over-year.
  • Maravai LifeSciences Holdings, Inc. noncontrolling interest, decrease from distributions to noncontrolling interest holders for the quarter ending 2023-12-31 was $0.00, a 100.00% decline year-over-year.
  • Maravai LifeSciences Holdings, Inc. noncontrolling interest, decrease from distributions to noncontrolling interest holders for fiscal 2024 was $494.00K, a 94.86% decline from fiscal 2023.
  • Maravai LifeSciences Holdings, Inc. noncontrolling interest, decrease from distributions to noncontrolling interest holders for fiscal 2023 was $9.61M, a 93.60% decline from fiscal 2022.
  • Maravai LifeSciences Holdings, Inc. noncontrolling interest, decrease from distributions to noncontrolling interest holders for fiscal 2022 was $150.06M, a 2.23% decline from fiscal 2021.
  • Maravai LifeSciences Holdings, Inc. noncontrolling interest, decrease from distributions to noncontrolling interest holders for fiscal 2021 was $153.49M.
Period endNoncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders 1 monthNoncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders 3 monthNoncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders 6 monthNoncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders 9 monthNoncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders 11 monthNoncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders 12 month
2024-12-31-$78.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18
-$78.00K
derived: sum of 2 quarters · filed 2025-11-07
$494.00K
derived: sum of 3 quarters · filed 2025-11-07
$494.00K
10-K · filed 2025-03-18
2024-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07
$572.00K
derived: sum of 2 quarters · filed 2025-11-07
$572.00K
10-Q · filed 2025-11-07
2024-06-30$572.00K
10-Q · filed 2025-08-11
$572.00K
10-Q · filed 2025-08-11
2023-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18
$0.00
derived: sum of 2 quarters · filed 2025-03-18
$1.30M
derived: sum of 3 quarters · filed 2025-03-18
$9.61M
10-K · filed 2025-03-18
2023-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12
$1.30M
derived: sum of 2 quarters · filed 2024-11-12
$9.61M
10-Q · filed 2024-11-12
$40.59M
derived: sum of 4 quarters · filed 2025-03-18
2023-06-30$1.30M
10-Q · filed 2024-08-08
$9.61M
10-Q · filed 2024-08-08
$40.59M
derived: sum of 3 quarters · filed 2025-03-18
$77.13M
derived: sum of 4 quarters · filed 2025-03-18
2023-03-31$8.30M
10-Q · filed 2024-05-09
$39.28M
derived: sum of 2 quarters · filed 2025-03-18
$75.83M
derived: sum of 3 quarters · filed 2025-03-18
$118.48M
derived: sum of 4 quarters · filed 2025-03-18
2022-12-31$30.98M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18
$67.52M
derived: sum of 2 quarters · filed 2025-03-18
$110.18M
derived: sum of 3 quarters · filed 2025-03-18
$150.06M
10-K · filed 2025-03-18
2022-09-30$36.54M
10-Q · filed 2023-11-08
$79.19M
derived: sum of 2 quarters · filed 2023-11-08
$119.08M
10-Q · filed 2023-11-08
$166.37M
derived: sum of 4 quarters · filed 2024-02-29
2022-06-30$42.65M
10-Q · filed 2023-08-08
$82.54M
10-Q · filed 2023-08-08
$129.83M
derived: sum of 3 quarters · filed 2024-02-29
$179.83M
derived: sum of 4 quarters · filed 2024-02-29
2022-03-31$39.89M
10-Q · filed 2023-05-09
$87.18M
derived: sum of 2 quarters · filed 2024-02-29
$137.18M
derived: sum of 3 quarters · filed 2024-02-29
$170.25M
derived: sum of 4 quarters · filed 2024-02-29
2021-12-31$47.29M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29
$97.29M
derived: sum of 2 quarters · filed 2024-02-29
$130.36M
derived: sum of 3 quarters · filed 2024-02-29
$153.49M
10-K · filed 2024-02-29
2021-09-30$50.00M
10-Q · filed 2022-11-04
$83.08M
derived: sum of 2 quarters · filed 2022-11-04
$106.20M
10-Q · filed 2022-11-04
2021-06-30$33.08M
10-Q · filed 2022-08-05
$56.20M
10-Q · filed 2022-08-05
2021-03-31$23.13M
10-Q · filed 2022-05-06
2020-12-31$8.17M
10-K · filed 2023-02-28
2020-11-19$88.88M
10-K · filed 2023-02-28
2020-09-30$122.00K
10-Q · filed 2021-11-15
$312.00K
derived: sum of 2 quarters · filed 2021-11-15
$312.00K
10-Q · filed 2021-11-15
2020-06-30$190.00K
10-Q · filed 2021-08-11
$190.00K
10-Q · filed 2021-08-11
2018-08-31$52.00M
10-K · filed 2023-02-28